Financhill
Back

Skyline Champion Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
60

SKY
Skyline Champion

Last Price:
78.21
Seasonality Move:
-0.74%
Sell
48

SRPT
Sarepta Therapeutics

Last Price:
148.17
Seasonality Move:
26.84%
Buy
60
Skyline Champion (SKY) is a Buy

Is Skyline Champion a Buy, Sell or Hold?

  • The current Skyline Champion [SKY] share price is $76.02. The Score for SKY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • SKY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $146.15. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SKY Stock Price Chart

What is Skyline Champion's stock price today?

  • The Skyline Champion share price today is $76.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SKY is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $146.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight selling pressure.

SKY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.82 Buy
Relative Strength Index (14 RSI): 57.7 Buy
Chaikin Money Flow: -204551 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (67.32 - 75.86) Buy
Bollinger Bands (100): (70.45 - 81.81) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.22 Buy
Relative Strength Index (14 RSI): 51.37 Buy
Chaikin Money Flow: -66137 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (139.83 - 159.79) Sell
Bollinger Bands (100): (118.79 - 143.95) Buy

SKY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 76.83 Sell
20-day SMA: 71.73 Buy
50-day SMA: 72.13 Buy
200-day SMA: 71.89 Buy
8-day EMA: 75.98 Buy
20-day EMA: 73.64 Buy
50-day EMA: 73.1 Buy
200-day EMA: 72.41 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 147.26 Sell
20-day SMA: 151.08 Sell
50-day SMA: 137.25 Buy
200-day SMA: 118.4 Buy
8-day EMA: 147.34 Sell
20-day EMA: 146.85 Sell
50-day EMA: 140.36 Buy
200-day EMA: 125.85 Buy

Skyline Champion Earnings Growth & SKY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.15 per share, a decrease this year of $3.75 per share, and a decrease next year of $0.16 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.

Skyline Champion Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):